BDSX vs. ASTH
BDSX (Biodesix, Inc.) and ASTH (Astrana Health Inc) are both stocks. Both are in the Healthcare sector — BDSX in Diagnostics & Research, ASTH in Medical Care Facilities. Over the past 5 years, BDSX returned -35.36%/yr vs -16.65%/yr for ASTH. Their 0.13 correlation means their historical movements had little consistent relationship.
Performance
BDSX vs. ASTH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BDSX achieves a 211.76% return, which is significantly higher than ASTH's 43.33% return.
BDSX
- 1D
- -0.63%
- 1M
- -3.59%
- 6M
- 108.46%
- YTD
- 211.76%
- 1Y
- 191.85%
- 3Y*
- -9.50%
- 5Y*
- -35.36%
- 10Y*
- —
- ALL TIME*
- -35.81%
ASTH
- 1D
- -3.05%
- 1M
- -27.68%
- 6M
- 56.38%
- YTD
- 43.33%
- 1Y
- 64.86%
- 3Y*
- -1.27%
- 5Y*
- -16.65%
- 10Y*
- 23.67%
- ALL TIME*
- 39.45%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $22.80M | $25.37M | $25.10M | |
BDSX Biodesix, Inc. | $1.31M | $1.38M | $1.40M |
BDSX vs. ASTH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
BDSX Biodesix, Inc. | 211.76% | -77.78% | -16.85% | -20.00% | -56.52% | -73.76% | 48.34% |
ASTH Astrana Health Inc | 43.33% | -21.31% | -17.68% | 29.44% | -59.73% | 302.19% | 1.11% |
Correlation
The correlation between BDSX and ASTH is -0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.02 |
Correlation (3Y) Balances recent behavior with more history. | 0.05 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.13 |
Correlation (All Time) Calculated using the full available price history since Oct 28, 2020 | 0.13 |
The correlation between BDSX and ASTH shifts across timeframes, from -0.02 (1 year) to 0.13 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
BDSX:
$172.57M
ASTH:
$1.76B
BDSX:
-$3.80
ASTH:
$0.61
BDSX:
1.85
ASTH:
0.50
BDSX:
22.42
ASTH:
2.18
BDSX:
$96.10M
ASTH:
$3.53B
BDSX:
$57.53M
ASTH:
$238.21M
BDSX:
-$20.16M
ASTH:
$125.28M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BDSX vs. ASTH — Risk / Return Rank
BDSX
ASTH
BDSX vs. ASTH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Biodesix, Inc. (BDSX) and Astrana Health Inc (ASTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BDSX | ASTH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.11 | ||
| Sortino ratioReturn per unit of downside risk | +1.37 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.21 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 4.11 | 1.06 | +3.05 |
| Martin ratioReturn relative to average drawdown | 8.49 | 2.34 | +6.15 |
Loading charts...
Drawdowns
BDSX vs. ASTH - Drawdown Comparison
The maximum BDSX drawdown since its inception was -99.30%, which is greater than ASTH's maximum drawdown of -84.80%. Use the drawdown chart below to compare losses from any high point for BDSX and ASTH.
Loading charts...
Drawdown Indicators
| BDSX | ASTH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.30% | -84.80% | -14.50% |
Max Drawdown (1Y)Largest decline over 1 year | -49.28% | -46.41% | -2.87% |
Max Drawdown (3Y)Largest decline over 3 years | -89.67% | -70.96% | -18.71% |
Max Drawdown (5Y)Largest decline over 5 years | -97.77% | -84.80% | -12.97% |
Max Drawdown (10Y)Largest decline over 10 years | — | -84.80% | — |
Current DrawdownCurrent decline from peak | -96.60% | -70.23% | -26.37% |
Average DrawdownAverage peak-to-trough decline | -85.98% | -47.26% | -38.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.82% | 21.02% | +2.80% |
Volatility
BDSX vs. ASTH - Volatility Comparison
Biodesix, Inc. (BDSX) has a higher volatility of 20.99% compared to Astrana Health Inc (ASTH) at 12.61%. This indicates that BDSX's price experiences larger fluctuations and is considered to be riskier than ASTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BDSX | ASTH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.99% | 12.61% | +8.38% |
Volatility (6M)Calculated over the trailing 6-month period | 64.03% | 42.54% | +21.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 113.53% | 72.83% | +40.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 103.39% | 62.15% | +41.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 101.58% | 91.31% | +10.27% |
Dividends
BDSX vs. ASTH - Dividend Comparison
Neither BDSX nor ASTH has paid dividends to shareholders.
Financials
BDSX vs. ASTH - Financials Comparison
This section allows you to compare key financial metrics between Biodesix, Inc. and Astrana Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BDSX vs. ASTH - Profitability Comparison
BDSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Biodesix, Inc. reported a gross profit of 0.00 and revenue of 25.56M. Therefore, the gross margin over that period was 0.0%.
ASTH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Astrana Health Inc reported a gross profit of 0.00 and revenue of 965.10M. Therefore, the gross margin over that period was 0.0%.
BDSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Biodesix, Inc. reported an operating income of -6.20M and revenue of 25.56M, resulting in an operating margin of -24.3%.
ASTH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Astrana Health Inc reported an operating income of 28.53M and revenue of 965.10M, resulting in an operating margin of 3.0%.
BDSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Biodesix, Inc. reported a net income of -7.79M and revenue of 25.56M, resulting in a net margin of -30.5%.
ASTH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Astrana Health Inc reported a net income of 14.44M and revenue of 965.10M, resulting in a net margin of 1.5%.
Frequently Asked Questions
BDSX and ASTH have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BDSX has higher volatility (20.99%) compared to ASTH (12.61%). In terms of maximum drawdown, BDSX dropped -99.30% vs ASTH's -84.80%.
BDSX currently has the higher Sharpe Ratio (1.79 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BDSX and ASTH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer